Source:EvaluatePharma
finallysawtheapprovalofthefirstagentsabletoslowtheprogressionofidiopathicpulmonaryfibrosis(IPF):Roche’sEsbrietandBoehringerIngelheim’sOfev.However,despitethesesuccessesinthenotoriouslydifficultindication,thesearchforacurecontinuesandthelate-stagepipelineisdepressinglybarren.WiththeterminationofGilead’sphaseIIstudyofsimtuzumabandAstraZenecastralokinumabtrialinJanuarychancesofmoreapprovalsinthenearfuturearebe早期白癜风能治好吗北京治疗白癜风价格
